Discontinuation report CORTENEMA
Report ID | 142328 |
Drug Identification Number | 02112736 |
Brand name | CORTENEMA |
Common or Proper name | Hydrocortisone suspension 100mg/60mL |
Company Name | APTALIS PHARMA CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCORTISONE |
Strength(s) | 100MG |
Dosage form(s) | ENEMA |
Route of administration | RECTAL RECTAL |
Packaging size | 60mL LDPE bottle |
ATC code | A07EA |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-10-01 |
Actual discontinuation date | 2021-11-15 |
Remaining supply date | 2021-11-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-12-03 | French | Compare |
v7 | 2021-12-03 | English | Compare |
v6 | 2021-11-17 | French | Compare |
v5 | 2021-11-17 | English | Compare |
v4 | 2021-07-21 | French | Compare |
v3 | 2021-07-21 | English | Compare |
v2 | 2021-07-12 | French | Compare |
v1 | 2021-07-12 | English | Compare |
Showing 1 to 8 of 8